- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wanbury Limited — Updates, 30-07-2026: Press Release
30-07-2026 | 10:04 am
30-07-2026 | 10:04 am
Wanbury received USFDA full compliance for its Metformin HCl API for multiple drug formulations, signaling strong US market potential. The company is also expanding its API business to South Korea with a new product filing.
No comments yet. Be the first to comment!